Эпизоды
-
Rina & Jean are back from their Tenerife pool parties and their last S2 podcast discusses their predictions for the new ABPI Code 2024 and changes at the PMCPA… Tune in again in Sept to see if any turn out to be right! But in the meantime thank you for listening and enjoy your summers ☀️
-
A new pharma employee asked us about using LinkedIn - hear our advice or access our checklist.
-
Пропущенные эпизоды?
-
Rina discusses a recent complaint vs GSK - it did not breach the Code but WHY? Jean asks all the questions a good signatory should be considering based on our checklist. See Code Clarity's LinkedIn page to see a similar TV ad.
-
Sophie Hodge from Medaptive shares her experience and recommendations on becoming a Signatory (spoiler alert - there's not a shortcut!)
-
Why are there still so many breaches about claims?! Rina & Jean discuss why these may appear and why pushing the boundaries is important.
-
LinkedIn does not allow promotion via InMail - a recent case (https://bit.ly/44y9YyB) vs Tetris tells us about targeting and the importance of social media platform policies.
-
Trends from Q1 published PMCPA rulings show a staggering 96% allege poor standards - what does this mean and what can we do about this?
-
Sarah Hollywood from HollywoodMedico chats to Jean about ' bad blocker' signatories and provides tips on how 'good' signatories can give teams the competitive edge.
-
Rubbish complaints cause confusing PMCPA rulings which lead to pharma's lack of clarity. Here are 5 top tips to lodge the "perfect" complaint to the PMCPA.
-
Three top tips from a good discussion about 2 cases and senior leader activities on social media - don't stop, challenge the PMCPA and appeals are worth it!!
Case AUTH/3741/2/23
Case AUTH/3707/11/22
-
We discuss the results of a recent LinkedIn poll and the ruling for Pfizer which suggest employees should review their past social media engagements - but that does not mean STOP engaging!
-
How to reduce confusion, encourage good record-keeping and stay complaint when briefing reps about call rates.
-
Sensational language, Mail article...yet no breach for GSK! Rina & Jean discuss why (Case AUTH/3691/9/22). A must listen for your comms team!
-
A LinkedIn poll recently confirmed that a compliance award could be based on bold ideas... Rina & Jean discuss why, what and how compliance can be celebrated alongside creativity. One for you and your agencies!
-
A recent case ruling (Case AUTH/3656/6/22) might leave you worried but we have three tips on how these interviews can be done well AND compliantly.
-
Our recent LinkedIn poll suggests 90% believe pharma's agencies should be Code-trained. Listen to our 3 top tips about the why, what and how representing best practice for ALL agencies.
-
Rina & Jean chat about how the PMCPA ruled (Case AUTH/3662/6/22) for a case about dynamic content generated from sharing buttons. Can they move? Should they be certified? Or simply checked?
-
Aargh with no definition of a promotional claim in the ABPI Code AND a terrible definition for a promotional aid, is it any wonder we are confused? Rina & Jean suggest a clear solution (after a little bit of moaning). See our comments and please send yours by 29 Feb 24, link here).
-
Rina & Jean discuss the proposed change in the 2024 Code for signatories requiring validation. Our top tips? Start PLANNING now, list out TASKS and COMMENT on the changes (see our comments and please send yours by 29 Feb 24, link here).
- Показать больше
